- Home
- PRTS vs CGTX Comparison
PRTS vs CGTX Comparison
Compare PRTS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- CGTX
- Stock Information
- Founded
- PRTS 1995
- CGTX 2007
- Country
- PRTS United States
- CGTX United States
- Employees
- PRTS N/A
- CGTX N/A
- Industry
- PRTS Auto & Home Supply Stores
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- CGTX Health Care
- Exchange
- PRTS Nasdaq
- CGTX Nasdaq
- Market Cap
- PRTS 48.0M
- CGTX 53.4M
- IPO Year
- PRTS 2007
- CGTX 2021
- Fundamental
- Price
- PRTS $0.74
- CGTX $1.67
- Analyst Decision
- PRTS Hold
- CGTX Strong Buy
- Analyst Count
- PRTS 1
- CGTX 3
- Target Price
- PRTS $0.70
- CGTX $2.83
- AVG Volume (30 Days)
- PRTS 636.3K
- CGTX 8.4M
- Earning Date
- PRTS 08-12-2025
- CGTX 08-07-2025
- Dividend Yield
- PRTS N/A
- CGTX N/A
- EPS Growth
- PRTS N/A
- CGTX N/A
- EPS
- PRTS N/A
- CGTX N/A
- Revenue
- PRTS $577,614,000.00
- CGTX N/A
- Revenue This Year
- PRTS $1.73
- CGTX N/A
- Revenue Next Year
- PRTS $5.48
- CGTX N/A
- P/E Ratio
- PRTS N/A
- CGTX N/A
- Revenue Growth
- PRTS N/A
- CGTX N/A
- 52 Week Low
- PRTS $0.68
- CGTX $0.22
- 52 Week High
- PRTS $1.42
- CGTX $1.97
- Technical
- Relative Strength Index (RSI)
- PRTS 45.40
- CGTX 78.08
- Support Level
- PRTS $0.73
- CGTX $1.40
- Resistance Level
- PRTS $0.94
- CGTX $1.97
- Average True Range (ATR)
- PRTS 0.06
- CGTX 0.21
- MACD
- PRTS -0.01
- CGTX 0.09
- Stochastic Oscillator
- PRTS 23.81
- CGTX 78.78
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.